What is New in Melanoma Genetics and Treatment?

Simone Ribero, Caterina Longo, Dan Glass, Paul Nathan, Veronique Bataille

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

New therapies for advanced melanoma have led to major advances, which, for the first time, showed improved survival for patients with this very challenging neoplasm. These new treatments are based on gene-targeted therapies or stimulation of immune responses. However, these treatments are not without challenges in terms of resistance and toxicity. Physicians should be aware of these side effects as prompt treatment may save lives. Melanoma genetics is also unravelling new genetic risk factors involving telomere genes as well as new gene pathways at the somatic level which may soon become therapeutic targets. It is also shedding new light onto the pathology of this tumour with links to neural diseases and longevity.

Original languageEnglish
Pages (from-to)259-264
Number of pages6
JournalDermatology
Volume232
Issue number3
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Melanoma
Therapeutics
Telomere
Genetic Therapy
Genes
Neoplasms
Pathology
Physicians
Survival

Keywords

  • Genetics
  • Melanoma
  • Therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Ribero, S., Longo, C., Glass, D., Nathan, P., & Bataille, V. (2016). What is New in Melanoma Genetics and Treatment? Dermatology, 232(3), 259-264. https://doi.org/10.1159/000445767

What is New in Melanoma Genetics and Treatment? / Ribero, Simone; Longo, Caterina; Glass, Dan; Nathan, Paul; Bataille, Veronique.

In: Dermatology, Vol. 232, No. 3, 01.06.2016, p. 259-264.

Research output: Contribution to journalReview article

Ribero, S, Longo, C, Glass, D, Nathan, P & Bataille, V 2016, 'What is New in Melanoma Genetics and Treatment?', Dermatology, vol. 232, no. 3, pp. 259-264. https://doi.org/10.1159/000445767
Ribero S, Longo C, Glass D, Nathan P, Bataille V. What is New in Melanoma Genetics and Treatment? Dermatology. 2016 Jun 1;232(3):259-264. https://doi.org/10.1159/000445767
Ribero, Simone ; Longo, Caterina ; Glass, Dan ; Nathan, Paul ; Bataille, Veronique. / What is New in Melanoma Genetics and Treatment?. In: Dermatology. 2016 ; Vol. 232, No. 3. pp. 259-264.
@article{d59770ce6dfb41a18c303d9c1cbac4c6,
title = "What is New in Melanoma Genetics and Treatment?",
abstract = "New therapies for advanced melanoma have led to major advances, which, for the first time, showed improved survival for patients with this very challenging neoplasm. These new treatments are based on gene-targeted therapies or stimulation of immune responses. However, these treatments are not without challenges in terms of resistance and toxicity. Physicians should be aware of these side effects as prompt treatment may save lives. Melanoma genetics is also unravelling new genetic risk factors involving telomere genes as well as new gene pathways at the somatic level which may soon become therapeutic targets. It is also shedding new light onto the pathology of this tumour with links to neural diseases and longevity.",
keywords = "Genetics, Melanoma, Therapy",
author = "Simone Ribero and Caterina Longo and Dan Glass and Paul Nathan and Veronique Bataille",
year = "2016",
month = "6",
day = "1",
doi = "10.1159/000445767",
language = "English",
volume = "232",
pages = "259--264",
journal = "Dermatology",
issn = "1018-8665",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - What is New in Melanoma Genetics and Treatment?

AU - Ribero, Simone

AU - Longo, Caterina

AU - Glass, Dan

AU - Nathan, Paul

AU - Bataille, Veronique

PY - 2016/6/1

Y1 - 2016/6/1

N2 - New therapies for advanced melanoma have led to major advances, which, for the first time, showed improved survival for patients with this very challenging neoplasm. These new treatments are based on gene-targeted therapies or stimulation of immune responses. However, these treatments are not without challenges in terms of resistance and toxicity. Physicians should be aware of these side effects as prompt treatment may save lives. Melanoma genetics is also unravelling new genetic risk factors involving telomere genes as well as new gene pathways at the somatic level which may soon become therapeutic targets. It is also shedding new light onto the pathology of this tumour with links to neural diseases and longevity.

AB - New therapies for advanced melanoma have led to major advances, which, for the first time, showed improved survival for patients with this very challenging neoplasm. These new treatments are based on gene-targeted therapies or stimulation of immune responses. However, these treatments are not without challenges in terms of resistance and toxicity. Physicians should be aware of these side effects as prompt treatment may save lives. Melanoma genetics is also unravelling new genetic risk factors involving telomere genes as well as new gene pathways at the somatic level which may soon become therapeutic targets. It is also shedding new light onto the pathology of this tumour with links to neural diseases and longevity.

KW - Genetics

KW - Melanoma

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84967138246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84967138246&partnerID=8YFLogxK

U2 - 10.1159/000445767

DO - 10.1159/000445767

M3 - Review article

AN - SCOPUS:84967138246

VL - 232

SP - 259

EP - 264

JO - Dermatology

JF - Dermatology

SN - 1018-8665

IS - 3

ER -